Skip to content
Events

Details

Workshop, 23 September 2-3pm CET

Illumina Global Response to Covid-19

  • The Pivotal Role of NGS in a Pandemic and Illumina’s Global Response​, Michael Oberholzer, Ph.D. Senior Staff Product Manager, Infectious Disease​
  • Illumina Technology Innovations Powering the COVID-19 Response​ and Illumina COVIDSeqTM Test for detection and surveillance of COVID-19​, Gary Schroth, Ph.D. Vice President and Distinguished Scientist, Emerging Applications​
  • Enrichment Workflow for Detection and Surveillance of Respiratory Viruses​, Jonathan Hetzel, Ph.D. Senior Scientist, Emerging Applications​
Date & Time
Sep 23, 2020 – Sep 25, 2020
Location
Online
Europe
This event has passed
For Research Use Only

Not for use in diagnostic procedures (except as specifically noted).

Innovative technologies

At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.

All trademarks are the property of Illumina, Inc. or their respective owners.
For specific trademark information, see www.illumina.com/company/legal.html.

© 2025 Illumina, Inc. All rights reserved.